AZZI, ALBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.152
EU - Europa 5.250
AS - Asia 2.982
SA - Sud America 356
AF - Africa 91
OC - Oceania 91
Continente sconosciuto - Info sul continente non disponibili 2
Totale 16.924
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.077
RU - Federazione Russa 1.719
IT - Italia 959
SG - Singapore 893
PL - Polonia 805
CN - Cina 647
HK - Hong Kong 501
SE - Svezia 459
IE - Irlanda 456
VN - Vietnam 306
BR - Brasile 272
KR - Corea 257
UA - Ucraina 208
DE - Germania 188
FI - Finlandia 147
FR - Francia 127
IN - India 103
AU - Australia 88
GB - Regno Unito 86
JO - Giordania 72
CA - Canada 44
CI - Costa d'Avorio 38
TR - Turchia 29
AR - Argentina 28
BD - Bangladesh 28
JP - Giappone 27
IQ - Iraq 23
MX - Messico 19
NG - Nigeria 18
NL - Olanda 17
AT - Austria 16
CH - Svizzera 16
CO - Colombia 16
ID - Indonesia 16
BE - Belgio 10
PY - Paraguay 10
EC - Ecuador 9
PK - Pakistan 9
SA - Arabia Saudita 9
VE - Venezuela 8
ZA - Sudafrica 8
ES - Italia 7
PH - Filippine 7
KZ - Kazakistan 6
MA - Marocco 6
OM - Oman 6
TW - Taiwan 6
AZ - Azerbaigian 5
EG - Egitto 5
SC - Seychelles 5
UY - Uruguay 5
KG - Kirghizistan 4
LT - Lituania 4
PE - Perù 4
TN - Tunisia 4
UZ - Uzbekistan 4
AL - Albania 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
EE - Estonia 3
IL - Israele 3
LK - Sri Lanka 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
SM - San Marino 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CL - Cile 2
DK - Danimarca 2
GT - Guatemala 2
HR - Croazia 2
IR - Iran 2
KE - Kenya 2
MK - Macedonia 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
A1 - Anonimo 1
AM - Armenia 1
AO - Angola 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
GE - Georgia 1
HN - Honduras 1
LB - Libano 1
NI - Nicaragua 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
Totale 16.924
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.913
Warsaw 804
Fairfield 702
Ashburn 700
Singapore 657
Chandler 513
Dublin 455
Hong Kong 402
Woodbridge 336
Jacksonville 323
Cambridge 292
San Jose 260
Houston 257
Seattle 256
Seoul 255
Milan 209
Wilmington 201
Beijing 186
The Dalles 133
Princeton 126
Ann Arbor 120
Buffalo 106
Rome 102
Lauterbourg 95
Ho Chi Minh City 94
Dallas 92
Melbourne 86
Florence 82
Mumbai 79
Boston 77
Kent 76
Los Angeles 74
Hanoi 69
Hefei 69
Medford 66
Boardman 59
Altamura 48
Munich 46
Lawrence 45
Moscow 43
Abidjan 38
San Diego 34
Shanghai 32
Council Bluffs 30
Norwalk 28
Redondo Beach 28
São Paulo 28
New York 23
Tokyo 23
Naples 22
Bari 20
Helsinki 20
Izmir 20
Figino 19
Da Nang 18
Abuja 17
Toronto 17
Turin 16
Wayne 16
London 15
Vienna 15
Brooklyn 14
Tianjin 14
Brescia 13
Frankfurt am Main 13
Phoenix 13
Hillsboro 12
Rio de Janeiro 12
Andover 10
Bologna 10
Guangzhou 10
Palermo 10
Saint Petersburg 10
Turku 10
Baghdad 9
Brussels 8
Clifton 8
Dong Ket 8
Falls Church 8
Jakarta 8
Orem 8
Padua 8
Atlanta 7
Parma 7
Sesto Fiorentino 7
Stockholm 7
Amsterdam 6
Belo Horizonte 6
Catania 6
Chicago 6
Denver 6
Frankfurt Am Main 6
Genoa 6
Haiphong 6
Hải Dương 6
Laurel 6
Montreal 6
Shenzhen 6
Venice 6
Verona 6
Totale 11.315
Salva come PNG Salva come JPEG
Nome #
Investigation of an imported case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013. 367
H3N2 Virus as Causative Agent of ARDS Requiring Extracorporeal Membrane Oxygenation Support 353
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. 334
Molecular markers of influenza B lineages and clades 329
Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). 304
Ventilatory and ECMO treatment of H1N1-induced severe respiratory failure: results of an Italian referral ECMO center 273
Artrite reumatoide e parvovirus B19: osservazioni preliminari 257
A real-time reverse transcriptase-polymer chain reaction to evaluate natural history of viral shedding in outpatient children and adolescents with pandemic 2009 influenza A(H1N1). 219
Human herpesviruses respiratory infections in patients with acute respiratory distress (ARDS) 216
Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab 209
Monitoring the susceptibility to oseltamivir of Influenza A(H1N1) 2009 virus by nested-PCR and pyrosequencing during the pandemic and in the season 2010-2011. 205
CONFUTAZIONE DI RECENTI IPOTESI ETIOLOGICHE PER LA PITIRIASI ROSEA DI GIBERT. 197
Tissue persistence of parvovirus B19 genotypes in asymptomatic persons 194
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures. 191
HA222 polymorphism in Influenza A(H1N1) 2009 isolates from Intensive Care Units and ambulatory patients during three influenza seasons. 191
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis. 190
Characterization of human H1N1 influenza virus variants selected In vitro with zanamivir in the presence of sialic acid-containing molecules 188
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy. 188
Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules. 187
Comparison of in vitro replication features of H7N3 influenza viruses from wild ducks and turkeys: potential implications for interspecies transmission. 186
The JCPYV DNA load inversely correlates with the viral microrna expression in blood and cerebrospinal fluid of patients at risk of PML 185
Reassortment ability of the 2009 pandemic H1N1 influenza virus with circulating human and avian influenza viruses: Public health risk implications 183
Human parvovirus B19 (B19V) infection in systemic sclerosis patients. 181
Different behavior of erythrovirus B19 and torquetenovirus in response to a single step of albumin purification. 180
PRESENCE OF TT VIRUS (TTV) DNA IN BONE MARROW CELLS FROM HAEMATOLOGIC PATIENTS 179
Effectiveness of nanofiltration in removing small non-enveloped viruses from three different plasma-derived products. 177
A FRET based melting curve analysis to detect nucleotide variations in HA receptor-binding site of H5N1 virus. 173
Archetypal and rearranged sequences of human polyomavirus JC transcription control region in peripheral blood leukocytes and in cerebrospinal fluid. 172
Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C (HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy. 172
Molecular surveillance of pandemic influenza A(H1N1) viruses circulating in Italy from May 2009 to February 2010: association between haemagglutinin mutations and clinical outcome. 170
Human parvovirus B19 infection in bone marrow transplantation patients 170
High resolution melting analysis as a tool to detect molecular markers of antiviral resistance in influenza A viruses. 170
Human polyomaviruses DNA detection in peripheral blood leukocytes from immunocompetent and immunocompromised individuals 169
BK virus regulatory region sequence deletions in a case of human polyomavirus associated nephropathy (PVAN) after kidney transplantation. 168
Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients. 167
Human herpesvirus 8 (HHV-8) DNA sequences are present in bone marrow from HIV-negative patients with lymphoproliferative disorders and from healthy blood donors. 157
Lymphocytopenia as a marker for pandemic influenza A/H1N1 2009 virus infection in children. 153
aplastic crisis caused by B19 virus in a child during induction therapy for acute lymphoblastic leukemia 153
Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization. 152
Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. 152
Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by nested polymerase chain reaction 152
Polyomavirus BK-specific immunity after kidney transplantation. 151
Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy. 150
Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients 147
Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: an underestimated infectious disease in the immunocompromised host. 145
Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. 144
Cryptococcus infection in immunodepressed subjects 142
Typing of European strains of parvovirus B19 by restriction endonuclease analyses and sequencing: identification of evolutionary lineages and evidence of recombination of markers from different lineages. 142
Analisi dell’espressione di microRNA prodotti dal Polyomavirus JC. 142
No association between human parvovirus B19 infection and Sjogren's syndrome. 141
Cryptococcose disséminée chez le chat. 140
Molecular adaptation of an H7N3 wild duck influenza virus following experimental multiple passages in quail and turkey. 139
Human parvovirus B19 infection within a family and risk for pregnant women 138
TT virus contaminates first-generation recombinant factor VIII concentrates. 137
Cytopenia caused by parvovirus in adult ALL patient 136
Inchiesta sulla diffusione della criptococcosi nei portatori di HIV in Italia 136
Cutaneous vasculitis due to human parvovirus B19 in an HIV-infected patient: report of a case. 135
Cryptococcose chez le chien: deux cas cliniques. 135
Detection of B19 parvovirus infections by dot-blot hybridization assay using a digoxigenin-labelled probe 134
Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated Factor VIII concentrate 133
Persistent parvovirus B19 infections with different clinical outcomes in renal transplant recipients: diagnostic relevance of polymerase chain reaction (PCR) and of quantification of B19 DNA in sera 130
Small RNAs targeting the 5' end of the viral polymerase gene segments specifically interfere with influenza type A virus replication 130
BKV e HPV nel sarcoma di Kaposi (KS) AIDS correlate 129
INTRAUTERINE PARVOVIRUS B19 INFECTION: EARLY PRENATAL DIAGNOSIS IS POSSIBLE. 128
Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. 128
Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis 128
I segnali di packaging alle estremità 5’ della regione codificante dei geni PA, PB1, E PB2 del virus dell’influenza come potenziali bersagli per lo sviluppo di antivirali. 127
Polymerase chain reaction for synthesis of digoxigenin-labelled DNA probe: application to parvovirus B19 and to polyomavirus BK 126
Parvovirus B19 infection in cultured skin fibroblasts from systemic sclerosis patients: a comment on the article of Ray et al. 125
Indagine epidemiologica sull'infezione da parvovirus B19 in diverse categorie 124
Parvovirus B19 and systemic sclerosis. 123
Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patients 123
Development of a Quantitative Competitive Polymerase Chain Reaction for Human Polyomavirus BK 122
Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation. 121
Multicentre Italian Study Group (MISG) for the standardisation of hepatitis C virus (HCV) PCR. 121
Isolation of influenza A(H3N2) virus with "O"-->"D" phase variation. 121
Increased pathogenicity and shedding in chickens of a wild bird origin LPAI virus of the H7N3 subtype following multiple in vivo passages in quail and turkey. 120
In vitro and ex vivo detection of human polyomavirus JC microRNA 119
Retransplantation after kidney graft loss due to polyoma BK virus nephropathy: successful outcome without original allograft nephrectomy. 119
Parvovirus B19 infection of bone marrow in systemic sclerosis patients 118
Use of denaturing gradient gel electrophoresis for human polyomavirus JC sequence analysis. 117
Unusual incidence of aplastic Anaemia due to B19 parvovirus infection in renal transplant recipients 117
NO ASSOCIATION BETWEEN HUMAN PARVOVIRUS B19 INFECTION AND SJÖGREN¿S SINDROME. 116
BK and JC viruses 116
Sorveglianza delle infezioni fungine nelle leucemie acute. 114
Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. 114
The transfusion-associated transmission of parvovirus B19. 114
Packaging signals in the 5' coding region of influenza virus PA, PB1, and PB2 genes as potential target to develop oligonucleotide based antiviral molecole. 113
Parvovirus B19 and systemic sclerosis 113
Severe aplastic anaemia due to B19 parvovirus infection in renal transpalnt recipient 112
Presence of TT virus DNA in bone marrow cells from hematologic patients. 108
Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow tranplantation patients 107
Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy. 106
Letter to Editor: Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated Factor VIII concentrate: the role of human B19 parvovirus 106
Monitoring of polyomavirus BK viruria in bone marrow transplantation patients by DNA hybridization assay and by polymerase chain reaction: an approach to assess the relationship between BK viruria and hemorrhagic cystitis. 103
First-generation recombinant factor VIII concentratesare free from viral contaminations? 99
Sonda marcata con digossigenina per la ricerca di BKV 99
Development of new antivirals against the influenza type A viruses based on small RNAs targeting the packaging signal of the polymarases gene coding region. 98
Parvovirus B19 infection in a patient with cutaneous vasculitis, arthralgia and paresthesia 98
Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogeneic bone marrow transplantation. 97
Totale 15.629
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.611
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.611
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022619 18 69 15 21 33 31 15 33 43 27 106 208
2022/20231.908 224 226 89 140 163 399 265 100 213 16 51 22
2023/2024617 37 84 123 23 34 32 24 94 9 33 83 41
2024/20254.923 168 551 311 717 1.436 900 61 272 201 74 148 84
2025/20264.485 571 626 351 240 547 164 596 207 257 229 101 596
2026/202767 67 0 0 0 0 0 0 0 0 0 0 0
Totale 16.986